Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $755.1 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.16.
Market Cap
755.1B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.16
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 195.86B | 0.45% | 1,233,072 | 45.20B |
| 2 | DHR | Danaher Corporation | 140.88B | 1.57% | 3,847,651 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.46B | 0.89% | 612,493 | 4.45B |
| 4 | NTRA | Natera, Inc. | 38.66B | -4.22% | 969,458 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.93B | 0.52% | 2,175,280 | 7.23B |
| 6 | WAT | Waters Corporation | 36.96B | -0.19% | 502,291 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 34.69B | -0.54% | 747,392 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 28.78B | -1.84% | 1,076,260 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.19B | 0.63% | 106,819 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.96B | -0.29% | 614,849 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.70B | -0.30% | 432,958 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 21.22B | -2.46% | 1,976,502 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.37B | 0.51% | 177,536 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 12.85B | -0.62% | 308,538 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.53B | -0.58% | 929,159 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.24B | -0.08% | 873,246 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.58B | -1.14% | 3,562,088 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.83B | -0.94% | 797,698 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.64B | -3.24% | 1,352,195 | 409.48M |
| 20 | SHC | Sotera Health Company | 5.25B | 0.16% | 2,304,822 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 5.16B | -0.52% | 376,123 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.55B | -3.93% | 757,185 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.37B | -3.39% | 1,907,792 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 3.09B | -5.00% | 509,860 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.95B | -5.40% | 643,813 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.84B | -4.21% | 1,377,837 | 745.97M |
| 27 | PSNL | Personalis, Inc. | 1.47B | -3.96% | 3,787,143 | 64.52M |
| 28 | CDNA | CareDx, Inc. | 1.47B | -2.06% | 665,778 | 412.82M |
| 29 | OPK | OPKO Health, Inc. | 1.02B | -2.88% | 2,060,929 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 719.43M | -3.42% | 207,334 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 583.63M | -1.58% | 211,585 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 550.63M | -4.43% | 856,979 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 221.82M | -3.30% | 97,953 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 164.03M | 4.74% | 146,569 | 1.95M |
| 35 | BNR | Burning Rock Biotech Limited | 119.17M | -3.42% | 25,689 | 74.58M |
| 36 | XGN | Exagen Inc. | 107.51M | -3.68% | 95,840 | 68.38M |
| 37 | PRPO | Precipio, Inc. | 42.54M | -10.12% | 143,334 | 25.83M |
| 38 | MDXH | MDxHealth SA | 24.45M | -2.84% | 473,097 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 19.94M | -4.90% | 719,957 | 537.08K |
| 40 | MBAI | Check-Cap Ltd. | 8.89M | -0.81% | 21,550 | - |
| 41 | ADVB | Advanced Biomed Inc. | 8.53M | -3.19% | 15,348 | - |
| 42 | XWEL | XWELL, Inc. | 8.04M | -4.35% | 67,594 | 28.83M |
| 43 | NDRA | ENDRA Life Sciences Inc. | 7.13M | 2.19% | 53,329 | - |
| 44 | ISPC | iSpecimen Inc. | 3.59M | -1.57% | 39,214 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.47M | -1.49% | 260,117 | 5.66M |